Delivery Order SPE2DB22D3501-SPE2DB25FVD71
Award Date
4/3/25
Potential Completion Date
4/4/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.6 mg colchicine capsules, with a ceiling value of $3,657.07 and a performance period ending on July 24, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMDNV, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,445.09 firm fixed-price delivery order is for the supply of 4566640101 - Colchicine 0.6 mg capsules in 100-count bottles. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. AmerisourceBergen holds a significant $999,999,999...
This contract award is an order for 4,567,072,377 units of Colchicine 0.6 mg capsules, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp. The $10,997.03 firm fixed-price delivery order has a completion date of January 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical through November 2026. This...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,135.96, is for the delivery of 4563818431 COLCHICINE 0.6 MG TABLET UD 30S. The contract has a completion date of March 1, 2024 and was awarded on February 29, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COLCHICINE 0.6 MG TABLET 100S, with a ceiling value of $1,358.53 and a period of performance extending to May 30, 2025. The contract is not set-aside and was awarded on May 29, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of mycophenolate 500 mg tablets. The contract has a ceiling value of $1,832.60 and a period of performance through August 5, 2024. The contract is a delivery order and utilizes a firm fixed-price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,088.64, is a delivery order for the provision of various pharmaceutical products and medical supplies. The contract has a completion date of December 31, 2024 and uses a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mycophenolate 500 mg tablets. The firm-fixed-price delivery order has a ceiling value of $2,991.75 and a period of performance through April 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $22,571.65 and an ultimate completion date of May 13, 2025. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to...
This federal contract award, with a ceiling value of $1,124.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and does not have a set-aside designation, indicating open competition. The contract covers the supply of a variety of pharmaceutical products and medical supplies, including medications across multiple...